Analysts Lower Targets for GoodRx Amid Sector Adjustments
Bank of America, Morgan Stanley, and Barclays have reduced price targets for GoodRx Holdings in recent weeks, while expressing varied outlooks on the broader healthcare sector.
Topic
Latest reporting and analysis tagged with price target.
Bank of America, Morgan Stanley, and Barclays have reduced price targets for GoodRx Holdings in recent weeks, while expressing varied outlooks on the broader healthcare sector.